Jan. 07, 2025 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

T2 Biosystems (NASDAQ:TTOO) Inc. shares have tumbled to a 52 ... This significant downturn reflects a staggering 1-year change, with the stock value eroding by nearly 95%. According to ...

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of ...

StockNews.com assumed coverage on shares of T2 Biosystems (NASDAQ:TTOO – Free Report) in a report released on Tuesday morning. The brokerage issued a sell rating on the medical equipment provider’s ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

There are no SEC filings that match your filter(s), please update your selections to return more records. Nasdaq provides company’s SEC filings, which are financial statements and reports filed ...